내시경 역행 담췌관 조영술(ERCP) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Endoscopic Retrograde Cholangiopancreatography Market size is expected to reach USD 6.33 Billion in 2034 from USD 2.99 Billion (2025) growing at a CAGR of 8.69% during 2026-2034.

The market for endoscopic retrograde cholangiopancreatography (ERCP) is advancing as gastrointestinal diagnostics and therapeutic interventions grow in demand. Technological innovations in endoscopes, stents, and guidewires are enhancing the precision, safety, and efficacy of ERCP procedures. The rising incidence of bile duct and pancreatic disorders, combined with advancements in minimally invasive techniques, is driving adoption in hospitals and specialty clinics worldwide.

Future growth will be shaped by next-generation imaging systems, robotics, and AI-powered diagnostic tools. Enhanced visualization through high-definition endoscopes and real-time analytics is improving detection rates and procedural success. Disposable ERCP devices are gaining importance, addressing infection control concerns and streamlining operational efficiency. Furthermore, training platforms with virtual reality and simulation tools are enhancing skill development among practitioners, ensuring wider adoption of advanced procedures.

The market outlook is reinforced by increasing investments in healthcare infrastructure and the globalization of specialized medical services. Collaborative partnerships between device manufacturers and research institutions are driving innovation pipelines, while regulatory emphasis on patient safety ensures continuous quality improvements. With technology redefining minimally invasive interventions, the ERCP market is positioned to expand as a critical component of advanced gastrointestinal care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Endoscopes
• Endotherapy Devices
• Visualization Systems
• Energy Devices
• Others

By Procedure

• Biliary Sphincterotomy
• Biliary Stenting
• Biliary Dilatation
• Pancreatic Sphincterotomy
• Pancreatic Duct Stenting
• Pancreatic Duct Dilation

By End Use

• Hospitals
• Outpatient Facilities

COMPANIES PROFILED

• Olympus Corporation, Conmed Corporation, Boston Scientific Corporation, Medtronic PLC, Telemed System Inc, Ambu Inc, Fujifilm Holdings Corporation, Hobbs Medical Inc, Cook Group, Streis PLC, HOYA Group, Karl Storz SE amp Co KG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Endoscopes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Endotherapy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Visualization Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Energy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Biliary Sphincterotomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biliary Stenting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Biliary Dilatation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pancreatic Sphincterotomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Pancreatic Duct Stenting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Pancreatic Duct Dilation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Procedure
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Procedure
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Procedure
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Procedure
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Procedure
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Olympus Corporation
  • 9.2.2 Conmed Corporation
  • 9.2.3 Boston Scientific Corporation
  • 9.2.4 Medtronic PLC
  • 9.2.5 Telemed System Inc
  • 9.2.6 Ambu Inc
  • 9.2.7 Fujifilm Holdings Corporation
  • 9.2.8 Hobbs Medical Inc
  • 9.2.9 Cook Group
  • 9.2.10 Streis PLC
  • 9.2.11 HOYA Group
  • 9.2.12 Karl Storz SE & Co. KG